Ibrahim Raphiou, Ph.D., is currently the Global Clinical Program Lead at AstraZeneca and a Senior Director of Clinical Development in Medical Affairs at Seres Therapeutics. Previously, Ibrahim held various roles at GlaxoSmithKline, including Medical Affairs Scientific Manager, Lead Clinical Development Scientist, and Medical Affairs Scientific Director from 2010 to 2015. Ibrahim earned a Doctor of Philosophy (Ph.D.) in Comparative Biomedical Sciences from North Carolina State University in 2002.
This person is not in the org chart
This person is not in any teams
This person is not in any offices